As an essential post-transcriptional regulation of PD-L1 expression, the potential immunoregulatory effects of multiple RBPs in several cancers, such as breast cancer [11, 12] and non-small cell lung cancer [13, 14], have been revealed. Here, CD274 is linked to non-small cell lung carcinoma.